PUBLISHER: The Business Research Company | PRODUCT CODE: 1669741
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669741
Devices for monitoring intracranial pressure (ICP) are medical tools utilized to measure and track the pressure within the skull and brain, particularly in patients facing conditions that may lead to elevated intracranial pressure.
The primary techniques employed in intracranial pressure (ICP) monitoring devices include both invasive and non-invasive approaches. Invasive techniques involve the use of monitoring devices or methods that necessitate the insertion of a probe or sensor directly into the intracranial space or a specific location within the brain. These techniques find application in various medical scenarios such as traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, cerebrospinal fluid (CSF) management, migraine, stroke, hydrocephalus, electroencephalogram (EEG), and others. These devices are utilized by hospitals, ambulatory care facilities, clinics, and various other end-users.
The intracranial pressure (ICP) monitoring devices market research report is one of a series of new reports from The Business Research Company that provides intracranial pressure (ICP) monitoring devices market statistics, including intracranial pressure (ICP) monitoring devices industry global market size, regional shares, competitors with an intracranial pressure (ICP) monitoring devices market share, detailed intracranial pressure (ICP) monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial pressure (ICP) monitoring devices industry. This intracranial pressure (ICP) monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intracranial pressure (ICP) monitoring devices market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing incidence of traumatic brain injuries (TBIs), aging population, growing awareness and diagnosis, medical tourism, rising geriatric population, global healthcare awareness and accessibility
The intracranial pressure (ICP) monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine approaches, telemedicine and remote monitoring, rise in chronic neurological disorders, integration with electronic health records (EHR), global increase in neurosurgical procedures, focus on outpatient monitoring. Major trends in the forecast period include artificial intelligence (AI) integration, continuous monitoring solutions, collaborations and partnerships, focus on non-invasive monitoring, home-based ICP monitoring.
The increasing incidence of traumatic brain injury (TBI) cases is anticipated to drive the growth of the intracranial pressure (ICP) monitoring devices market in the future. Traumatic brain injury refers to damage to the brain resulting from an external force or trauma. The rise in TBI cases is primarily attributed to a higher number of motor vehicle accidents, sports injuries, and physical assaults. ICP monitoring devices are essential in managing TBI cases as they provide real-time data regarding the pressure within the skull. For example, in April 2024, the American Association of Neurological Surgeons, a US-based scientific and educational organization, reported from the CDC that approximately 1.7 to 3.8 million traumatic brain injuries occur each year in the United States, with 10 percent stemming from sports and recreational activities. Consequently, the increasing prevalence of traumatic brain injury cases is fueling the demand for intracranial pressure monitoring devices.
The growth of the intracranial pressure (ICP) monitoring device market is expected to be fueled by the increasing prevalence of neurological diseases. Neurological diseases, encompassing a wide range of medical conditions affecting the nervous system, rely on intracranial pressure (ICP) monitoring devices for crucial insights into skull pressure management. The World Health Organization (WHO) reported in February 2023 that epilepsy, a neurological disorder, impacts 5 million individuals globally, with varying incidence rates in high-income and low- to middle-income countries. The rise in neurological diseases is a significant factor contributing to the growth of the intracranial pressure (ICP) monitoring device market.
Major companies in the market are actively seeking partnerships to fortify their market positions. For example, in November 2022, Sweden-based medical technology company IRRAS partnered with U.S.-based medical device company Medtronic, granting Medtronic exclusive rights to promote the IRRAflow system in specific U.S. territories. Another partnership in November 2022 involved U.S.-based EMOTIV collaborating with Israel-based X-trodes to launch a medical-grade, at-home solution for brain monitoring research, leveraging EMOTIV's expertise in electroencephalography (EEG) and X-trodes' wireless medical-grade monitoring solutions.
Major players in the intracranial pressure (ICP) monitoring device market are dedicating their efforts to developing cutting-edge therapies and treatments, exemplified by innovations such as the high-dose cohort of CTI-1601 and the SOMNUM AI device, aimed at elevating patient outcomes. The high-dose cohort of CTI-1601 represents a promising treatment for Friedreich's ataxia, a rare genetic disease. In a notable development, Larimar Therapeutics Inc., a biotechnology company based in the United States, obtained approval for the high-dose cohort of CTI-1601 in October 2023. Additionally, the SOMNUM AI device, designed for intracranial pressure monitoring and traumatic brain injury (TBI), received approval from the U.S. Food and Drug Administration (FDA). This strategic focus on innovative therapies reflects a commitment to advancing patient care in the intracranial pressure monitoring device market.
In January 2023, Natus Medical Incorporated, a prominent medical device company headquartered in the United States, successfully completed the acquisition of Micromed Holding SAS for an undisclosed amount. The primary objective behind this acquisition was to enhance Natus Medical's capabilities in the neurophysiology market, encompassing the diagnosis and monitoring of various neurological disorders and conditions. The collaboration between Natus Medical's existing product portfolio and Micromed's offerings presents opportunities for enhanced integration, innovation, and customer support within the neurophysiology market. Notably, Micromed Holding SAS is a U.S.-based provider of neurophysiology solutions and operates within the intracranial pressure (ICP) monitoring devices market.
Major companies operating in the intracranial pressure (ICP) monitoring devices market include Medtronic plc, Integra LifeSciences Holding Corporation, Natus Medical Inc., Haiying Medical, Raumedic AG, Sophysa Ltd., Ad-Tech Medical Instrument Corp., Third Eye Diagnostics, Boston Neurosciences Inc., DePuy Synthes, Codman & Shurtleff Inc., NeuroWave Systems Inc., Branchpoint Technologies Inc., Cerebrotech Medical Systems Inc., Deltex Medical Group plc, Gaeltec Devices Ltd., Infrascan Inc., NeuroDx Development, NeuroVent Research Inc., Noninvasix, Vivonics Inc., Neural Analytics, Spiegelberg GmbH and Co. KG, HeadSense Medical Ltd., Moberg ICU Solutions, Nisonic AS, Vittamed Corporation, Cerebral Assessment Systems Inc., Orsan Medical Technologies Ltd.
North America was the largest region in the intracranial pressure (ICP) monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intracranial pressure (icp) monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intracranial pressure (icp) monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The intracranial pressure (ICP) monitoring devices market consists of sales of intraparenchymal monitors, subdural monitors, epidural monitors, and ventricular catheters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intracranial Pressure (ICP) Monitoring Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on intracranial pressure (icp) monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intracranial pressure (icp) monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intracranial pressure (icp) monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.